Inside the World’s Leading Cannabis Company | Boris Jordan, Chairman & CEO, Curaleaf

On today’s episode of Higher Exchanges, we’re joined by Boris Jordan, Chairman and CEO of Curaleaf, to discuss what may be the most important policy and capital markets moment the cannabis industry has seen in years. We explore Curaleaf’s perspective on federal rescheduling — what it could actually change for operators, when it may become final, and whether additional catalysts like SAFER banking, uplisting, or even descheduling could follow. Boris also shares how the company is thinking about the evolving political landscape and what is realistically achievable under the next administration. We then dive into Curaleaf’s shifting strategy around hemp. After entering the category in 2018, exiting in 2023, reentering with hemp-derived THC in 2024, and now stepping away again, Boris explains what changed in the market, how regulatory dynamics are shaping the category, and what conditions could bring Curaleaf back to hemp in the future. The conversation also covers capital markets and consolidation across the industry. With Curaleaf recently completing a $500 million refinancing and signs of financing markets beginning to thaw, Boris discusses how operators are approaching capital, whether deal activity is truly returning, and where consolidation may emerge next. Finally, we look inside Curaleaf itself — from the balance between domestic and international growth to maintaining margins during years of price compression. Boris walks through Curaleaf’s “Built for Growth” strategy, how the company is allocating capital across markets, and what investors may be missing when evaluating the largest cannabis operator in the world. A wide-ranging discussion on policy catalysts, industry structure, and what the next phase of growth could look like for cannabis. Higher Exchanges is powered by Flowhub.